Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Critical Reviews in Oncology/Hematology|April 12, 2026
Epidermal Growth Factor Receptor (EGFR) atypical mutations in Non-Small-Cell Lung Cancer (NSCLC): 'where the streets have no name'Gianluca Spitaleri, Pamela Trillo Aliaga, Gianluca Alessio Mariani, et al.
Tumori|July 25, 2012
Capecitabine in elderly patients with metastatic breast cancerRita De Sanctis, Silvia Quadrini, Flavia Longo, et al.
Clinical Lung Cancer|October 31, 2025
Actionable Gene Alterations in Resected Non-Small Cell Lung Cancer: Primary Results From the AGA-R StudyIlaria Attili, Gloria Pellizzari, Luca Bertolaccini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 17, 2010
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapyFlavia Longo, Giovanni Mansueto, Vittoria Lapadula, et al.
Journal of Thoracic Disease|December 5, 2017
The role of multimodal treatment in patients with advanced lung neuroendocrine tumorsNicola Fazio, Antonio Ungaro, Francesca Spada, et al.
Journal of Clinical Medicine|August 10, 2024
Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective AnalysisIlaria Attili, Riccardo Asnaghi, Davide Vacirca, et al.
Critical Reviews in Oncology/Hematology|February 2, 2024
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approachGiovanni Luca Ceresoli, Giulio Rossi, Francesco Agustoni, et al.
The Oncologist|February 20, 2024
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb TrialEmilio Bria, Floriana Morgillo, Marina Chiara Garassino, et al.
Clinical Lung Cancer|July 30, 2025
The Italian Mauris Phase IIIb Trial of Atezolizumab Plus Carboplatin and Etoposide for Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer: 3-Year End-of-Study ResultsFloriana Morgillo, Ester Del Signore, Emilio Bria, et al.
Pageof 4